Lawrence M Mcglynn, MD
Psychiatry · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mcglynn’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A72906 · Current
Licensed to practise in California · since 2000 · expires 2027-12-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$88,386
Medicare paid this office $88,386 for 41 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Psychotherapy with evaluation and management visit, 1 hour | 28 | $28,915 | $108 |
| Return visit (30+ min) | 32 | $27,272 | $116 |
| Short return visit (20+ min) | 24 | $8,760 | $88 |
| Psychotherapy with evaluation and management visit, 1 hour | 15 | $5,871 | $90 |
| Return visit (30+ min) | 13 | $4,529 | $84 |
Who their Medicare patients are
41 Original Medicare patients in 2024. Average age 63 · Under 65 56% · Also on Medicaid 61% · Health risk score 1.39. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 63% · High blood pressure 41%.
The office billed $517,988, Medicare allowed $114,906 and paid $88,386; for 873 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 41 | 873 | 63 | 1.39 | $517,988 | $88,386 |
| 2023 | 44 | 852 | 62 | 1.43 | $505,475 | $70,774 |
| 2022 | 45 | 741 | 61 | 1.58 | $486,858 | $63,617 |
| 2021 | 44 | 715 | 61 | 1.57 | $447,029 | $63,411 |
| 2020 | 75 | 834 | 59 | 1.57 | $354,748 | $63,332 |
| 2019 | 80 | 779 | 60 | 1.83 | $196,016 | $50,367 |
| 2018 | 87 | 839 | 58 | 1.90 | $144,437 | $47,702 |
| 2017 | 98 | 861 | 56 | 2.04 | $205,534 | $51,971 |
| 2016 | 106 | 851 | 56 | 1.77 | $253,176 | $55,200 |
| 2015 | 96 | 786 | 56 | 1.85 | $216,901 | $60,841 |
| 2014 | 110 | 968 | 54 | 1.60 | $210,114 | $68,424 |
| 2013 | 109 | 1,060 | 55 | 1.64 | $200,021 | $44,934 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 35 | $21,271 | $86 |
| Psychotherapy with evaluation and management visit, 1 hour | 32 | $18,516 | $89 |
| Psychotherapy with evaluation and management visit, 1 hour | 13 | $9,497 | $92 |
| Return visit (30+ min) | 15 | $8,907 | $82 |
| Psychotherapy with evaluation and management visit, 30 minutes | 11 | $949 | $56 |
2022: 3 services
| Return visit (30+ min) | 37 | $18,233 | $84 |
| Psychotherapy with evaluation and management visit, 1 hour | 32 | $15,027 | $87 |
| Psychotherapy with evaluation and management visit, 45 minutes | 18 | $2,777 | $71 |
2021: 4 services
| Return visit (30+ min) | 30 | $12,597 | $93 |
| Long return visit (40+ min) | 27 | $11,315 | $126 |
| Psychotherapy with evaluation and management visit, 1 hour | 22 | $7,520 | $96 |
| Psychotherapy with evaluation and management visit, 45 minutes | 30 | $7,404 | $66 |
2020: 10 services
| Psychotherapy with evaluation and management visit, 45 minutes | 32 | $13,645 | $72 |
| Long return visit (40+ min) | 28 | $10,409 | $104 |
| Return visit (30+ min) | 56 | $8,329 | $61 |
| Telephone medical discussion with physician, 21-30 minutes | 36 | $7,998 | $75 |
| Psychotherapy with evaluation and management visit, 45 minutes | 16 | $5,230 | $75 |
| Long return visit (40+ min) | 12 | $4,771 | $106 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $4,657 | $97 |
| Return visit (30+ min) | 12 | $2,529 | $74 |
| Psychotherapy with evaluation and management visit, 30 minutes | 15 | $1,076 | $51 |
| Short return visit (20+ min) | 11 | $569 | $38 |
2019: 5 services
| Return visit (30+ min) | 70 | $22,530 | $70 |
| Psychotherapy with evaluation and management visit, 45 minutes | 30 | $12,174 | $70 |
| Return visit (30+ min) | 12 | $4,880 | $68 |
| Psychotherapy with evaluation and management visit, 45 minutes | 12 | $4,850 | $71 |
| Short return visit (20+ min) | 39 | $3,346 | $38 |
2018: 8 services
| Psychotherapy with evaluation and management visit, 45 minutes | 30 | $13,162 | $69 |
| Return visit (30+ min) | 40 | $12,132 | $68 |
| Short return visit (20+ min) | 52 | $7,444 | $41 |
| Psychotherapy with evaluation and management visit, 30 minutes | 29 | $4,494 | $52 |
| Short return visit (20+ min) | 26 | $4,285 | $42 |
| Psychotherapy with evaluation and management visit, 45 minutes | 13 | $2,893 | $71 |
| Return visit (30+ min) | 18 | $1,837 | $63 |
| Psychotherapy with evaluation and management visit, 30 minutes | 11 | $745 | $57 |
2017: 6 services
| Psychotherapy with evaluation and management visit, 45 minutes | 37 | $17,307 | $69 |
| Return visit (30+ min) | 39 | $15,375 | $75 |
| Short return visit (20+ min) | 52 | $7,194 | $41 |
| Short return visit (20+ min) | 34 | $5,412 | $49 |
| Psychotherapy with evaluation and management visit, 30 minutes | 28 | $2,905 | $52 |
| Return visit (30+ min) | 25 | $2,883 | $66 |
2016: 6 services
| Psychotherapy with evaluation and management visit, 45 minutes | 31 | $16,041 | $71 |
| Return visit (30+ min) | 45 | $13,015 | $82 |
| Short return visit (20+ min) | 42 | $10,416 | $65 |
| Short return visit (20+ min) | 56 | $7,653 | $44 |
| Return visit (30+ min) | 40 | $4,400 | $66 |
| Psychotherapy with evaluation and management visit, 30 minutes | 25 | $2,266 | $55 |
2015: 4 services
| Return visit (30+ min) | 79 | $33,757 | $94 |
| Psychotherapy with evaluation and management visit, 45 minutes | 28 | $12,656 | $69 |
| Short return visit (20+ min) | 34 | $9,422 | $64 |
| Psychotherapy with evaluation and management visit, 30 minutes | 24 | $3,618 | $53 |
2014: 4 services
| Return visit (30+ min) | 78 | $28,943 | $99 |
| Short return visit (20+ min) | 92 | $21,118 | $62 |
| Psychotherapy with evaluation and management visit, 30 minutes | 71 | $8,338 | $55 |
| Psychotherapy with evaluation and management visit, 45 minutes | 28 | $7,334 | $72 |
2013: 8 services
| Return visit (30+ min) | 84 | $20,720 | $56 |
| Short return visit (20+ min) | 52 | $6,552 | $62 |
| Psychotherapy with evaluation and management visit, 45 minutes | 34 | $5,832 | $46 |
| Psychotherapy with evaluation and management visit, 30 minutes | 70 | $5,566 | $28 |
| Psychotherapy, 45 minutes | 31 | $2,224 | $41 |
| Return visit (30+ min) | 15 | $1,541 | $86 |
| Short return visit (20+ min) | 30 | $1,065 | $29 |
| Psychiatric services complicated by communication factor | 48 | $443 | $3 |
Medicaid work
$5,580 in 2024
Medicaid paid $5,580 for 205 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Psychotherapy, 60 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 84 | $3,095 |
| Return visit (30+ min) | 121 | $2,485 |
| 2024 | 205 | 2 | 21 | $5,580 |
| 2023 | 609 | 2 | 22 | $16,509 |
| 2022 | 469 | 2 | 19 | $15,084 |
| 2021 | 72 | 2 | 14 | $1,577 |
| 2020 | 54 | 1 | 21 | $614 |
| 2019 | 54 | 2 | 26 | $575 |
| 2018 | 229 | 1 | 28 | $1,651 |
See the largest Medicaid services in earlier years
2023
| Psychotherapy, 60 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 269 | $10,724 |
| Return visit (30+ min) | 340 | $5,785 |
2022
| Psychotherapy, 60 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 202 | $9,671 |
| Return visit (30+ min) | 267 | $5,413 |
2021
| Return visit (30+ min) | 48 | $1,012 |
| Psychotherapy, 45 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 24 | $565 |
2020
| Return visit (30+ min) | 54 | $614 |
2019
| Short return visit (20+ min) | 29 | $391 |
| Return visit (30+ min) | 25 | $185 |
2018
| Short return visit (20+ min) | 229 | $1,651 |
Drugs they prescribed that Part D paid
$218,582
Pharmacies billed $218,582 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
555 generic and 71 brand-name prescriptions · $218,582 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Serostim | 13 | $129,154 | $9,935 |
| Trintellix | 11 | $5,216 | $474 |
| Belsomra | 12 | $5,104 | $425 |
| Aripiprazole | 27 | $4,066 | $151 |
| Duloxetine | 27 | $1,652 | $61 |
See all 22 drugs
| Serostim | 13 | $129,154 | $9,935 |
| Trintellix | 11 | $5,216 | $474 |
| Belsomra | 12 | $5,104 | $425 |
| Aripiprazole | 27 | $4,066 | $151 |
| Duloxetine | 27 | $1,652 | $61 |
| Testosterone | 12 | $1,430 | $119 |
| Quetiapine | 34 | $1,344 | $40 |
| Dextroamphetamine-Amphetamine | 32 | $1,194 | $37 |
| Bupropion Xl | 26 | $733 | $28 |
| Hydroxyzine | 12 | $468 | $39 |
| Gabapentin | 34 | $326 | $10 |
| Divalproex | 12 | $274 | $23 |
| Nystatin | 11 | $269 | $24 |
| Mirtazapine | 44 | $243 | $6 |
| Lamotrigine | 28 | $145 | $5 |
| Diazepam | 32 | $126 | $4 |
| Clonazepam | 22 | $121 | $5 |
| Trazodone | 19 | $92 | $5 |
| Escitalopram | 11 | $79 | $7 |
| Lorazepam | 29 | $74 | $3 |
| Buspirone | 12 | $67 | $6 |
| Doxepin | 11 | $22 | $2 |
Year by year
| 2024 | 626 | 50 | None | 11% | $218,582 |
| 2023 | 654 | 56 | 2% (14) | 12% | $168,555 |
| 2022 | 742 | 49 | 2% (14) | 6% | $72,297 |
| 2021 | 818 | 64 | 2% (16) | 6% | $100,869 |
| 2020 | 1,378 | 84 | 1% (17) | 10% | $190,789 |
| 2019 | 1,476 | 94 | 2% (28) | 12% | $184,964 |
| 2018 | 1,516 | 107 | 3% (38) | 13% | $162,058 |
| 2017 | 1,518 | 109 | 6% (95) | 12% | $179,764 |
| 2016 | 1,330 | 100 | 7% (94) | 10% | $129,739 |
| 2015 | 1,281 | 97 | 8% (100) | 17% | $185,603 |
| 2014 | 1,681 | 94 | 8% (134) | None | $309,126 |
| 2013 | 1,646 | 93 | 7% (116) | 34% | $375,300 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Descovy | 11 | $25,651 | $2,332 |
| Belsomra | 18 | $7,778 | $432 |
| Duloxetine | 38 | $3,111 | $82 |
| Testosterone | 15 | $1,986 | $132 |
| Dextroamphetamine-Amphetamine | 27 | $1,269 | $47 |
| Aripiprazole | 31 | $1,253 | $40 |
| Quetiapine | 44 | $1,012 | $23 |
| Bupropion Xl | 28 | $614 | $22 |
| Gabapentin | 25 | $474 | $19 |
| Clonazepam | 36 | $420 | $12 |
| Hydroxyzine | 11 | $412 | $37 |
| Mirtazapine | 30 | $405 | $13 |
| Oxycodone | 12 | $300 | $25 |
| Prazosin | 11 | $264 | $24 |
| Trazodone | 30 | $249 | $8 |
| Escitalopram | 34 | $238 | $7 |
| Lamotrigine | 30 | $158 | $5 |
| Diazepam | 21 | $104 | $5 |
| Lorazepam | 18 | $96 | $5 |
2022: 21 drugs
| Aripiprazole | 33 | $9,743 | $295 |
| Testosterone | 12 | $1,920 | $160 |
| Duloxetine | 98 | $1,686 | $17 |
| Dextroamphetamine-Amphetamine | 25 | $1,330 | $53 |
| Bupropion Xl | 27 | $1,078 | $40 |
| Quetiapine | 39 | $878 | $23 |
| Prazosin | 13 | $786 | $60 |
| Mirtazapine | 39 | $719 | $18 |
| Divalproex | 11 | $343 | $31 |
| Oxycodone | 12 | $306 | $26 |
| Pramipexole Dihydrochloride | 11 | $287 | $26 |
| Lamotrigine | 32 | $263 | $8 |
| Gabapentin | 37 | $217 | $6 |
| Lorazepam | 31 | $216 | $7 |
| Hydroxyzine | 19 | $197 | $10 |
| Zolpidem | 27 | $197 | $7 |
| Clonazepam | 41 | $135 | $3 |
| Trazodone | 29 | $118 | $4 |
| Diazepam | 24 | $92 | $4 |
| Escitalopram | 13 | $79 | $6 |
| Clonidine | 11 | $47 | $4 |
2021: 22 drugs
| Duloxetine | 98 | $2,893 | $30 |
| Testosterone | 12 | $2,311 | $193 |
| Dextroamphetamine-Amphetamine | 34 | $1,857 | $55 |
| Pramipexole Dihydrochloride | 13 | $1,286 | $99 |
| Bupropion Xl | 27 | $1,029 | $38 |
| Aripiprazole | 42 | $947 | $23 |
| Mirtazapine | 57 | $872 | $15 |
| Dextroamphetamine Sulfate | 12 | $575 | $48 |
| Quetiapine | 30 | $568 | $19 |
| Temazepam | 25 | $380 | $15 |
| Clindamycin Phosphate | 11 | $342 | $31 |
| Oxycodone | 13 | $318 | $24 |
| Gabapentin | 41 | $317 | $8 |
| Clonazepam | 42 | $283 | $7 |
| Lorazepam | 40 | $239 | $6 |
| Trazodone | 21 | $204 | $10 |
| Diazepam | 39 | $197 | $5 |
| Lamotrigine | 27 | $166 | $6 |
| Risperidone | 13 | $157 | $12 |
| Lithium Carbonate | 17 | $96 | $6 |
| Fluoxetine | 14 | $78 | $6 |
| Hydroxyzine | 11 | $61 | $6 |
2020: 34 drugs
| Genvoya | 13 | $43,079 | $3,314 |
| Odefsey | 13 | $38,928 | $2,994 |
| Risperdal Consta | 18 | $14,508 | $806 |
| Dextroamphetamine-Amphetamine | 48 | $2,365 | $49 |
| Testosterone | 12 | $2,311 | $193 |
| Bupropion Xl | 80 | $2,261 | $28 |
| Aripiprazole | 71 | $1,909 | $27 |
| Duloxetine | 59 | $1,151 | $20 |
| Quetiapine | 106 | $1,067 | $10 |
| Mirtazapine | 54 | $691 | $13 |
| Bupropion Hcl Sr | 32 | $669 | $21 |
| Methylphenidate | 23 | $615 | $27 |
| Clonazepam | 91 | $589 | $6 |
| Modafinil | 12 | $501 | $42 |
| Lorazepam | 68 | $486 | $7 |
| Trazodone | 53 | $471 | $9 |
| Dextroamphetamine Sulfate | 22 | $457 | $21 |
| Propranolol | 32 | $385 | $12 |
| Oxycodone | 12 | $338 | $28 |
| Venlafaxine Hcl Er | 25 | $324 | $13 |
| Amitriptyline | 17 | $309 | $18 |
| Gabapentin | 40 | $293 | $7 |
| Hydroxyzine | 25 | $282 | $11 |
| Lamotrigine | 40 | $245 | $6 |
| Olanzapine | 13 | $214 | $16 |
| Diazepam | 44 | $193 | $4 |
| Paroxetine | 24 | $179 | $7 |
| Fluoxetine | 23 | $153 | $7 |
| Sertraline | 49 | $135 | $3 |
| Lithium Carbonate | 16 | $117 | $7 |
| Zolpidem | 14 | $95 | $7 |
| Citalopram Hbr | 14 | $93 | $7 |
| Buspirone | 14 | $68 | $5 |
| Topiramate | 15 | $46 | $3 |
2019: 36 drugs
| Descovy | 11 | $19,295 | $1,754 |
| Aripiprazole | 77 | $16,707 | $217 |
| Risperdal Consta | 16 | $11,764 | $735 |
| Dronabinol | 20 | $9,363 | $468 |
| Lyrica | 13 | $5,980 | $460 |
| Methylphenidate Er | 27 | $5,333 | $198 |
| Oxandrolone | 14 | $4,573 | $327 |
| Testosterone | 20 | $4,341 | $217 |
| Dextroamphetamine-Amphetamine | 54 | $2,464 | $46 |
| Bupropion Xl | 68 | $2,215 | $33 |
| Dextroamphetamine Sulfate | 24 | $1,400 | $58 |
| Methylphenidate | 40 | $1,184 | $30 |
| Bupropion Hcl Sr | 47 | $1,080 | $23 |
| Gabapentin | 44 | $814 | $19 |
| Duloxetine | 45 | $807 | $18 |
| Mirtazapine | 39 | $779 | $20 |
| Quetiapine | 63 | $705 | $11 |
| Venlafaxine Hcl Er | 31 | $612 | $20 |
| Oxycodone | 18 | $602 | $33 |
| Lorazepam | 91 | $584 | $6 |
| Clonazepam | 82 | $474 | $6 |
| Sertraline | 65 | $401 | $6 |
| Propranolol | 20 | $389 | $19 |
| Divalproex Sodium Er | 13 | $375 | $29 |
| Trazodone | 59 | $335 | $6 |
| Buspirone | 30 | $266 | $9 |
| Zolpidem | 43 | $261 | $6 |
| Olanzapine | 24 | $205 | $9 |
| Fluoxetine | 16 | $186 | $12 |
| Lithium Carbonate | 23 | $171 | $7 |
| Risperidone | 11 | $134 | $12 |
| Paroxetine | 14 | $133 | $9 |
| Diazepam | 31 | $131 | $4 |
| Lamotrigine | 19 | $102 | $5 |
| Atorvastatin | 12 | $72 | $6 |
| Topiramate | 16 | $65 | $4 |
2018: 39 drugs
| Descovy | 14 | $23,651 | $1,689 |
| Tivicay | 11 | $18,413 | $1,674 |
| Risperdal Consta | 23 | $15,866 | $690 |
| Aripiprazole | 85 | $15,639 | $184 |
| Edurant | 13 | $13,173 | $1,013 |
| Testosterone | 16 | $4,354 | $272 |
| Oxandrolone | 13 | $4,272 | $329 |
| Methylphenidate Er | 19 | $3,717 | $196 |
| Dronabinol | 12 | $3,708 | $309 |
| Dextroamphetamine-Amphetamine | 48 | $2,223 | $46 |
| Quetiapine | 82 | $1,630 | $20 |
| Duloxetine | 37 | $1,495 | $40 |
| Methylphenidate | 35 | $1,338 | $38 |
| Bupropion Xl | 60 | $1,300 | $22 |
| Bupropion Hcl Sr | 27 | $1,291 | $48 |
| Memantine | 13 | $986 | $76 |
| Divalproex Sodium Er | 18 | $862 | $48 |
| Prazosin | 27 | $818 | $30 |
| Mirtazapine | 41 | $645 | $16 |
| Olanzapine | 51 | $571 | $11 |
| Gabapentin | 50 | $520 | $10 |
| Lorazepam | 94 | $515 | $5 |
| Propranolol | 28 | $513 | $18 |
| Clonazepam | 93 | $510 | $5 |
| Oxycodone | 19 | $469 | $25 |
| Sertraline | 54 | $428 | $8 |
| Trazodone | 67 | $397 | $6 |
| Venlafaxine Hcl Er | 18 | $307 | $17 |
| Zolpidem | 41 | $285 | $7 |
| Lithium Carbonate Er | 21 | $275 | $13 |
| Paroxetine | 24 | $259 | $11 |
| Lithium Carbonate | 23 | $243 | $11 |
| Topiramate | 26 | $218 | $8 |
| Hydrocodone-Acetaminophen | 11 | $204 | $19 |
| Buspirone | 18 | $124 | $7 |
| Fluoxetine | 11 | $111 | $10 |
| Diazepam | 20 | $104 | $5 |
| Lamotrigine | 17 | $76 | $4 |
| Alprazolam | 13 | $48 | $4 |
2017: 40 drugs
| Aripiprazole | 62 | $17,458 | $282 |
| Descovy | 11 | $16,995 | $1,545 |
| Testosterone | 13 | $4,593 | $353 |
| Divalproex Sodium Er | 29 | $4,289 | $148 |
| Chantix | 11 | $3,962 | $360 |
| Oxandrolone | 11 | $3,627 | $330 |
| Methylphenidate Er | 20 | $3,290 | $165 |
| Norvir | 12 | $3,033 | $253 |
| Modafinil | 23 | $2,898 | $126 |
| Dextroamphetamine-Amphetamine | 51 | $2,853 | $56 |
| Methylphenidate | 29 | $2,828 | $98 |
| Dextroamphetamine Sulfate | 17 | $2,325 | $137 |
| Duloxetine | 47 | $1,836 | $39 |
| Morphine Sulfate Er | 20 | $1,595 | $80 |
| Quetiapine | 84 | $1,373 | $16 |
| Bupropion Xl | 49 | $1,143 | $23 |
| Prazosin | 30 | $986 | $33 |
| Oxycodone | 26 | $967 | $37 |
| Oxycodone-Acetaminophen | 12 | $763 | $64 |
| Clonazepam | 74 | $698 | $9 |
| Mirtazapine | 44 | $627 | $14 |
| Hydrocodone-Acetaminophen | 30 | $522 | $17 |
| Trazodone | 72 | $518 | $7 |
| Lorazepam | 83 | $505 | $6 |
| Propranolol | 27 | $470 | $17 |
| Divalproex | 15 | $450 | $30 |
| Olanzapine | 37 | $338 | $9 |
| Zolpidem | 51 | $315 | $6 |
| Lithium Carbonate | 34 | $315 | $9 |
| Fluoxetine | 25 | $303 | $12 |
| Topiramate | 30 | $297 | $10 |
| Lamotrigine | 25 | $264 | $11 |
| Venlafaxine Hcl Er | 29 | $228 | $8 |
| Sertraline | 33 | $215 | $7 |
| Ketoconazole | 11 | $174 | $16 |
| Buspirone | 13 | $157 | $12 |
| Gabapentin | 23 | $131 | $6 |
| Paroxetine | 15 | $120 | $8 |
| Alprazolam | 13 | $107 | $8 |
| Diazepam | 21 | $100 | $5 |
2016: 34 drugs
| Triumeq | 11 | $26,809 | $2,437 |
| Aripiprazole | 59 | $19,962 | $338 |
| Dextroamphetamine-Amphetamine | 63 | $5,245 | $83 |
| Dextroamphetamine Sulfate | 26 | $4,265 | $164 |
| Methylphenidate | 48 | $3,682 | $77 |
| Testosterone | 12 | $3,637 | $303 |
| Suboxone | 12 | $3,193 | $266 |
| Oxandrolone | 11 | $3,007 | $273 |
| Morphine Sulfate Er | 14 | $2,131 | $152 |
| Quetiapine | 72 | $1,946 | $27 |
| Divalproex Sodium Er | 14 | $1,699 | $121 |
| Oxycodone | 33 | $1,152 | $35 |
| Duloxetine | 25 | $1,000 | $40 |
| Olanzapine | 22 | $949 | $43 |
| Bupropion Hcl Sr | 27 | $944 | $35 |
| Hydrocodone-Acetaminophen | 29 | $826 | $28 |
| Bupropion Xl | 35 | $783 | $22 |
| Mirtazapine | 37 | $668 | $18 |
| Clonazepam | 73 | $625 | $9 |
| Baclofen | 23 | $625 | $27 |
| Zolpidem | 54 | $571 | $11 |
| Lorazepam | 82 | $531 | $6 |
| Propranolol | 26 | $442 | $17 |
| Pramipexole Dihydrochloride | 22 | $425 | $19 |
| Trazodone | 60 | $418 | $7 |
| Fluoxetine | 32 | $310 | $10 |
| Venlafaxine Hcl Er | 35 | $239 | $7 |
| Topiramate | 25 | $219 | $9 |
| Prazosin | 11 | $206 | $19 |
| Lamotrigine | 29 | $149 | $5 |
| Lithium Carbonate | 21 | $149 | $7 |
| Paroxetine | 23 | $122 | $5 |
| Sertraline | 16 | $59 | $4 |
| Diazepam | 20 | $59 | $3 |
2015: 37 drugs
| Abilify | 33 | $40,344 | $1,223 |
| Dronabinol | 16 | $8,984 | $562 |
| Aripiprazole | 11 | $7,454 | $678 |
| Dextroamphetamine-Amphetamine | 62 | $4,673 | $75 |
| Dextroamphetamine Sulfate | 27 | $4,253 | $158 |
| Oxandrolone | 12 | $3,959 | $330 |
| Methylphenidate | 43 | $3,792 | $88 |
| Suboxone | 12 | $3,787 | $316 |
| Adderall | 11 | $3,275 | $298 |
| Divalproex Sodium Er | 17 | $2,975 | $175 |
| Morphine Sulfate Er | 19 | $2,883 | $152 |
| Methylphenidate Er | 12 | $2,340 | $195 |
| Dextroamphetamine-Amphet Er | 13 | $2,235 | $172 |
| Modafinil | 11 | $1,938 | $176 |
| Oxycodone | 36 | $1,533 | $43 |
| Quetiapine | 67 | $1,335 | $20 |
| Ritalin | 19 | $1,330 | $70 |
| Hydrocodone-Acetaminophen | 36 | $1,063 | $30 |
| Mirtazapine | 68 | $923 | $14 |
| Duloxetine | 11 | $827 | $75 |
| Bupropion Hcl Sr | 26 | $788 | $30 |
| Bupropion Xl | 30 | $729 | $24 |
| Clonazepam | 90 | $565 | $6 |
| Zolpidem | 70 | $524 | $7 |
| Olanzapine | 18 | $469 | $26 |
| Lorazepam | 65 | $410 | $6 |
| Trazodone | 56 | $351 | $6 |
| Propranolol | 19 | $268 | $14 |
| Lithium Carbonate | 19 | $251 | $13 |
| Venlafaxine Hcl Er | 22 | $221 | $10 |
| Gabapentin | 12 | $171 | $14 |
| Topiramate | 24 | $133 | $6 |
| Fluoxetine | 23 | $131 | $6 |
| Risperidone | 14 | $123 | $9 |
| Lamotrigine | 17 | $114 | $7 |
| Escitalopram | 13 | $85 | $7 |
| Citalopram Hbr | 17 | $51 | $3 |
2014: 35 drugs
| Abilify | 111 | $97,252 | $876 |
| Truvada | 30 | $42,035 | $1,401 |
| Dronabinol | 34 | $24,713 | $727 |
| Complera | 11 | $23,444 | $2,131 |
| Duloxetine | 60 | $10,516 | $175 |
| Dextroamphetamine Sulfate | 33 | $7,731 | $234 |
| Amphetamine Salt Combo | 73 | $6,179 | $85 |
| Quetiapine | 69 | $4,724 | $68 |
| Oxandrolone | 13 | $3,717 | $286 |
| Morphine Sulfate Er | 19 | $2,929 | $154 |
| Methylphenidate | 33 | $2,751 | $83 |
| Oxycontin | 13 | $2,452 | $189 |
| Oxycodone | 49 | $2,220 | $45 |
| Divalproex Sodium Er | 15 | $2,145 | $143 |
| Mirtazapine | 124 | $1,204 | $10 |
| Olanzapine | 42 | $1,010 | $24 |
| Zolpidem | 82 | $1,002 | $12 |
| Lorazepam | 147 | $917 | $6 |
| Hydrocodone-Acetaminophen | 42 | $752 | $18 |
| Clonazepam | 111 | $722 | $7 |
| Bupropion Xl | 28 | $706 | $25 |
| Bupropion Hcl Sr | 39 | $652 | $17 |
| Venlafaxine Hcl Er | 18 | $498 | $28 |
| Risperidone | 38 | $396 | $10 |
| Sertraline | 29 | $207 | $7 |
| Trazodone | 29 | $192 | $7 |
| Atorvastatin | 23 | $189 | $8 |
| Fluoxetine | 16 | $150 | $9 |
| Citalopram Hbr | 21 | $132 | $6 |
| Topiramate | 12 | $122 | $10 |
| Escitalopram | 13 | $118 | $9 |
| Buspirone | 11 | $110 | $10 |
| Propranolol | 18 | $81 | $4 |
| Gabapentin | 11 | $69 | $6 |
| Alprazolam | 13 | $64 | $5 |
2013: 46 drugs
| Abilify | 108 | $73,332 | $679 |
| Truvada | 33 | $46,670 | $1,414 |
| Reyataz | 23 | $30,389 | $1,321 |
| Dronabinol | 21 | $28,444 | $1,354 |
| Intelence | 29 | $25,585 | $882 |
| Cymbalta | 72 | $23,006 | $320 |
| Marinol | 24 | $14,450 | $602 |
| Prezista | 12 | $13,358 | $1,113 |
| Selzentry | 12 | $13,210 | $1,101 |
| Norvir | 16 | $10,844 | $678 |
| Dextroamphetamine Sulfate | 41 | $8,899 | $217 |
| Amphetamine Salt Combo | 66 | $7,299 | $111 |
| Modafinil | 12 | $6,773 | $564 |
| Olanzapine | 41 | $5,336 | $130 |
| Oxandrolone | 12 | $4,494 | $375 |
| Quetiapine | 49 | $3,790 | $77 |
| Testim | 11 | $3,621 | $329 |
| Namenda | 12 | $3,216 | $268 |
| Morphine Sulfate Er | 24 | $2,324 | $97 |
| Escitalopram | 28 | $1,934 | $69 |
| Bupropion Hcl Sr | 46 | $1,688 | $37 |
| Oxycodone | 38 | $1,537 | $40 |
| Methylphenidate | 18 | $1,428 | $79 |
| Divalproex Sodium Er | 24 | $1,233 | $51 |
| Mirtazapine | 94 | $902 | $10 |
| Lorazepam | 93 | $806 | $9 |
| Risperidone | 36 | $783 | $22 |
| Clonazepam | 92 | $773 | $8 |
| Budeprion Sr | 28 | $727 | $26 |
| Bupropion Xl | 16 | $486 | $30 |
| Oxycodone-Acetaminophen | 21 | $482 | $23 |
| Hydroxyzine | 12 | $325 | $27 |
| Divalproex | 21 | $304 | $14 |
| Zolpidem | 51 | $277 | $5 |
| Sertraline | 32 | $268 | $8 |
| Venlafaxine Hcl Er | 14 | $221 | $16 |
| Lithium Carbonate | 27 | $219 | $8 |
| Topiramate | 22 | $219 | $10 |
| Hydrocodone-Acetaminophen | 18 | $207 | $12 |
| Acyclovir | 11 | $206 | $19 |
| Trazodone | 23 | $201 | $9 |
| Fluoxetine | 18 | $196 | $11 |
| Buspirone | 13 | $182 | $14 |
| Paroxetine | 11 | $155 | $14 |
| Citalopram Hbr | 15 | $89 | $6 |
| Diazepam | 11 | $70 | $6 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1144386954
- Licence
- CA A72906California A72906: Current · expires 2027-12-31
- Trained
- Harvard Medical School, 1996
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-12-28
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3801 Miranda Ave, Palo Alto, CA, 94304